Trials / Conditions / Blasts 10 Percent or More of Bone Marrow Nucleated Cells
Blasts 10 Percent or More of Bone Marrow Nucleated Cells
4 registered clinical trials studyying Blasts 10 Percent or More of Bone Marrow Nucleated Cells — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML NCT04220684 | Sumithira Vasu | Phase 1 |
| Recruiting | Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood NCT03589729 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grad NCT02756572 | University of Washington | Phase 2 |
| Recruiting | Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk NCT02115295 | M.D. Anderson Cancer Center | Phase 2 |